Medipal Holdings (TSE:7459) Change In Payables And Accrued Expense : 円0 Mil (TTM As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Medipal Holdings Change In Payables And Accrued Expense?

Medipal Holdings's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was 円0 Mil. It means Medipal Holdings's Accounts Payable & Accrued Expense stayed the same from Sep. 2023 to Dec. 2023 .

Medipal Holdings's Change In Payables And Accrued Expense for the fiscal year that ended in Mar. 2024 was 円0 Mil. It means Medipal Holdings's Accounts Payable & Accrued Expense stayed the same from Mar. 2023 to Mar. 2024 .

Medipal Holdings Change In Payables And Accrued Expense Historical Data

The historical data trend for Medipal Holdings's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipal Holdings Change In Payables And Accrued Expense Chart

Medipal Holdings Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Medipal Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Medipal Holdings Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

Medipal Holdings Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Medipal Holdings's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Medipal Holdings (TSE:7459) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medipal Holdings Corp (TSE:7459) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

MEPDF:USA MAHLY:USA 59Z:Germany

Address

2-7-15, Yaesu, Chuo-ku, Tokyo, JPN, 104-8461

Website

http://www.medipal.co.jp

Medipal Holdings Corp distributes pharmaceuticals and health and beauty products to medical institutions and retailers. The firm operates in three segments: prescription pharmaceutical wholesale; cosmetics, daily necessities, and OTC pharmaceutical wholesale; and animal health products wholesale. The prescription pharmaceutical business generates the majority of revenue and distributes products to hospitals, clinics, and pharmacies. The cosmetics, daily necessities, and OTC pharmaceutical businesses distribute products to drugstores, convenience stores, and supermarkets. The animal health segment conducts wholesale business for animal hospitals, farms, and agricultural cooperatives. Medipal Holdings generates the vast majority of its revenue in Japan.

Medipal Holdings (TSE:7459) Headlines

No Headlines